Reproductive Embryo Editing: Attending to Justice
By Inmaculada De Melo-Martín,
The Hastings Center Report
| 08. 22. 2022
Advances in genome editing technologies allow scientists to add, remove, or alter genetic material at particular locations in the human genome. Genome editing of somatic cells offers great promise in the prevention and treatment of various human diseases. But these technologies could also be used to modify gametes and embryos. Some commentators defend gene editing for reproductive purposes on the ground that it would allow people who are at risk of transmitting genetic diseases to their offspring to have healthy and genetically related children.
Using gene editing in this way would require further research. The technology still presents problems involving off-target effects and reliability. Researchers must improve delivery to desired tissues and control of immunogenic reactions. Yet I argue here that, if we accept certain background claims about justice, accepting the goal of helping people have healthy and genetically related children should commit one to rejecting the investment of social resources into further development of reproductive embryo editing.
Considerations of justice are relevant to questions regarding the development of reproductive embryo editing for several reasons. First, decisions about research-funding priorities involve...
Related Articles
By staff, Japan Times | 12.04.2025
Japan plans to introduce a ban with penalties on implanting a genome-edited fertilized human egg into the womb of a human or another animal amid concerns over "designer babies."
A government expert panel broadly approved a proposal, including the ban...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Tina Stevens, CounterPunch | 12.11.2025
Silicon Valley and other high tech billionaires are investing millions in start-ups dedicated to creating genetically engineered (GE) babies, according to a recent Wall Street Journal (WSJ) report. AI mogul Sam Altman, cryptocurrency entrepreneur Brian Armstrong, venture capitalist Peter...
By Jenny Lange, BioNews | 12.01.2025
A UK toddler with a rare genetic condition was the first person to receive a new gene therapy that appears to halt disease progression.
Oliver, now three years old, has Hunter syndrome, an inherited genetic disorder that leads to physical...